Linear systems analysis of activating processes of complement system as a defense mechanism

BioSystems

Volumn 39, Issue 3, 1996, Pages 173-185

  Hirayama, Hirohumi ^a   Yoshii, Kiyono ^a   Ojima, Hidetomo ^a   Kawai, Norikazu ^a   Gotoh, Shintaro ^a   Fukuyama, Yuzo ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Complement; Controllability; Optimization; Sequential activation; Stability

Indexed keywords

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HOST RESISTANCE; KINETICS; LINEAR SYSTEM; SYSTEM ANALYSIS;

EID: 0029779290     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-2647(96)01617-6     Document Type: Article

References (27)

1. [1] Alsenz, J. and Schulz, T.F. 1985, Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 232, 841-850.
2. [2] Biesecker, G. and Muller Enerhard, H.J. 1980. The 9 th component of human complement : Purification and physicochemical characterization. J. Immunol. 124(3), 1291-1296.
3. [3] Aras, I.W., Davitz, M.A., Rhee, L., Weddell, G. and Martin D.W. 1987, Cloning of decay-accelerating factor suggest novel use of splicing to generate two proteins. Nature 325, 545-549.
4. [4] Haupt, H. and Heimburger, N. 1970. Ein Betrag zur isolierung und charaktersierung des C1-inaktivators aus human plasma. Eur. J. Biochem. 17, 254-261.
5. [5] Havsteen, B.H. and Varo, N.R. 1990. Kinetics of the classical complement activation cascade. J. Theor. Bio. 145, 47-64.
6. [6] Hamilton, K.K., Zhao, Ji. and Sims, P.J. 1993. Interaction betwween Apolipoproteins A-I and A-II and the membrane attack complex of complement. J. Biol. Chem. 268. 5, 3632-3638.
7. [7] Klein, J. 1982. Immunology. The Science of self-nonself discrimination. New York. Wiley, pp. 313-216.
8. [8] Lachmann, P.J. 1991. The control of homologous lysis. Immunol. Today 12, 312-315.
9. [9] Mitomo, K., Fujita, T. and Iida, K. 1987. Functional and antigenic properties of complement receptor type 2, CR2. J. Exp. Med. 165, 1424-1429.
10. [10] Monahan, J.B. and Sodetz, J.M. 1980. Binding of the 8 th component of human complement to th soluble cytolytic complex is mediated by its β subunit. J. Biol. Chem. 255, 10579-10582.
11. [11] Muller-Eberhard, H.J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321-347.
12. [12] Muller-Eberhard, H.J. 1975. Complement. Annu. Rev. Biochem. 44, pp. 697-724.
13. [13] Pangburn, M.K. and Muller-Eberhard, H.J. 1986. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem. J. 235, 723-730.
14. [14] Podack, E.R., Biesecker, G., Kolb, W.P. and Muller-Eberhard, H.J. 1978. The C5b-C6 complex : reaction with C7, C8, C9. J. Immunol. 121, 484-490.
15. [15] Podack, E.R., Preissner, K.T. and Muller-Eberhard, H.J. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S protein. 1984. Acta. Pathol. Microbiol. Immunol. Scand. 92, 89-96.
16. [16] Podack, E.R., Kolb, W.P. and Muller Enerhard, H.J. 1976 Purification of the 6th and 7th component of human complement without loss of hemolytic activity. J. Immunol. 116, No2, 263-269.
17. [17] Pontryagin, L.S. 1962. The mathematical theory of the optimal process. J. Wiley.
18. [18] Ross, G.D. and Medof, M.E. 1985. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol. 37. 217-267.
19. [19] Schumaker, V.N., Calcott, M.A., Spiegelberg, H.L. and Muller-Eberhard, H.J. 1976. Ultra centrifugal studies of the binding of IgG of different subclass to C1q subunit of the first component of complement. Biochemistry 15, 5175-5181.
20. [20] Seya, T., Turne, J.R. and Atkinson J.P. 1986. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163, 837-855.
21. [21] Strunk, R. and Colten, H.R. 1974. The first component of human complement Cl. J. Immunol. 112, 905-910.
22. [22] Takata, Y., Kinosita, T., Kozono H., Takeda J. and Tanaka, E. 1987. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. J. Exp. Med. 163, 1494-1507.
23. [23] Vogt, W., Schmidt, G., Von Buttlar. and B. Dieminger L. 1978. A new function of the activated third component : binding to c5 an essential step for C5 activation. Immunology 34, 29-40.
24. [24] Zeit, J.H., Zeff, R.A., Gewurz, H. and Lint, T.F. 1983. Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eight component of complement. J. Immunol. 130, 2809-2813.
25. [25] Ziccardi, R.J., Dahlback, B. and Muller Eberhard, H. 1984. Characterization of the inter action of human C4b-binding protein with physiological ligands. J. Biol. Chem. 259, 13674-13678.
26. [26] Ziccardi, R.J. and Cooper, N.R. 1977. The subunit composition ad sedimentation properties of human C1. J. Immunol. 118, 2047-2052.
27. [27] Ziccardi, R. 1981. Activation of the early components of the classical component pathway under physiological conditions. J. Immunol. 126, 1769-1773.